These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 3373260

  • 1. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
    Ardalan B, Singh G, Silberman H.
    J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
    [Abstract] [Full Text] [Related]

  • 2. Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
    Ardalan B, Stridhar K, Reddy R, Benedetto P, Richman S, Waldman S, Morrell L, Feun L, Savaraj N, Livingstone A.
    Int J Radiat Oncol Biol Phys; 1992 Jun; 22(3):511-4. PubMed ID: 1735689
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B, Ucar A, Reddy R, Livingstone AS, Markoe A, Schwade J, Richman SP, Donofrio K.
    Cancer; 1994 Oct 01; 74(7):1869-73. PubMed ID: 8082092
    [Abstract] [Full Text] [Related]

  • 4. Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
    Erlichman C, Donehower RC, Speyer JL, Klecker R, Chabner BA.
    J Natl Cancer Inst; 1982 Feb 01; 68(2):227-31. PubMed ID: 6950156
    [Abstract] [Full Text] [Related]

  • 5. A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
    Ardalan B, Sridhar KS, Benedetto P, Richman S, Waldman S, Morrell L, Feun L, Savaraj N, Fodor M, Livingstone A.
    Cancer; 1991 Sep 15; 68(6):1242-6. PubMed ID: 1873776
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy for colorectal cancer with a combination of PALA and 5-FU.
    Bedikian AY, Stroehlein JR, Karlin DA, Bennetts RW, Bodey GP, Valdivieso M.
    Cancer Treat Rep; 1981 Sep 15; 65(9-10):747-53. PubMed ID: 7273010
    [Abstract] [Full Text] [Related]

  • 7. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB.
    J Clin Oncol; 2001 May 01; 19(9):2413-21. PubMed ID: 11331320
    [Abstract] [Full Text] [Related]

  • 8. A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer.
    Jodrell DI, Oster W, Kerr DJ, Canney PA, Yosef H, Steward WP, Kaye SB, Cassidy J.
    Eur J Cancer; 1994 May 01; 30A(7):950-5. PubMed ID: 7946590
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU.
    Weiss GR, Ervin TJ, Meshad MW, Kufe DW.
    Cancer Treat Rep; 1982 Feb 01; 66(2):299-303. PubMed ID: 7055815
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.
    Fleming RA, Capizzi RL, Muss HB, Smith S, Fernandes DJ, Homesley H, Loggie BW, Case L, Morris R, Russell GB, Richards F.
    Clin Cancer Res; 1996 Jul 01; 2(7):1107-14. PubMed ID: 9816275
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
    Kemeny N, Conti JA, Seiter K, Niedzwiecki D, Botet J, Martin D, Costa P, Wiseberg J, McCulloch W.
    J Clin Oncol; 1992 May 01; 10(5):747-52. PubMed ID: 1569447
    [Abstract] [Full Text] [Related]

  • 15. Continuous five-day infusion of PALA and 5FU: a pilot phase II trial.
    Presant CA, Ardalan B, Multhauf P, Chan C, Staples R, Green L, Browning S, Carr BI, Chang FF, Thayer W.
    Med Pediatr Oncol; 1983 May 01; 11(3):162-3. PubMed ID: 6222250
    [Abstract] [Full Text] [Related]

  • 16. A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU.
    Weiss GR, Ervin TJ, Meshad MW, Schade D, Branfman AR, Bruni RJ, Chadwick M, Kufe DW.
    Cancer Chemother Pharmacol; 1982 May 01; 8(3):301-4. PubMed ID: 7127661
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of combination therapy with PALA and 5-FU.
    Meshad MW, Ervin TJ, Kufe D, Johnson RK, Blum RH, Frei E.
    Cancer Treat Rep; 1981 May 01; 65(3-4):331-4. PubMed ID: 6263472
    [Abstract] [Full Text] [Related]

  • 18. Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.
    O'Connell MJ, Moertel CG, Rubin J, Hahn RG, Kvols LK, Schutt AJ.
    J Clin Oncol; 1984 Oct 01; 2(10):1133-8. PubMed ID: 6491697
    [Abstract] [Full Text] [Related]

  • 19. Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II study.
    Chiuten DF, Miller A, Valdivieso M, Loo TL, Bedikian A, Bodey GP, Benvenuto JA, Freireich EJ.
    Am J Clin Oncol; 1985 Aug 01; 8(4):332-5. PubMed ID: 4083263
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.
    Rosvold E, Schilder R, Walczak J, DiFino SM, Flynn PJ, Banerjee TK, Heim WJ, Engstrom PF, Ozols RF, O'Dwyer PJ.
    Cancer Chemother Pharmacol; 1992 Aug 01; 29(4):305-8. PubMed ID: 1537077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.